Skip to content

NBIX

Neurocrine Biosciences, Inc.

Revenue to net income

Key figures

MetricLatest5-year CAGR
Revenue$3.7B+22.3%
Gross profit$3.6B+22.1%
Operating income$887M+30.6%
Net income$703M+3.3%
EPS$6.74+2.3%
Free cash flow$749M2025+28.0%